202 related articles for article (PubMed ID: 4511385)
1. [L-dopa treatment of parkinsonism].
Szulc-Kuberska J; Niewodniczy A; Poźniak-Patewicz E; Wolczyk-Orzechowska M
Neurol Neurochir Pol; 1973; 7(1):63-8. PubMed ID: 4511385
[No Abstract] [Full Text] [Related]
2. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
Wycis HT
Confin Neurol; 1972; 34(2):130-5. PubMed ID: 4666056
[No Abstract] [Full Text] [Related]
3. [Treatment of Parkinson's disease with L-dopa and with a combination of L-dopa and dopa-decarboxylase inhibitor].
Agnoli A; Casacchia M; Reitano M; Ruggieri S; Barba C; Zamponi A
Minerva Med; 1972 Dec; 63(89):4853-61. PubMed ID: 4566743
[No Abstract] [Full Text] [Related]
4. [Treatment of Parkinsonic syndrome with levo-Dopa. Case reports].
Rosati G; Agnetti V; Mura F; Granieri E
Minerva Med; 1974 May; 65(33):1811-23. PubMed ID: 4602058
[No Abstract] [Full Text] [Related]
5. [2-year experiences with a combination treatment of Parkinsonism with L-dopa and a decarboxylase inhibitor (Benserazid, Ro 4-4602)].
Birkmayer W; Linauer W; Mentasti M; Riederer P
Wien Med Wochenschr; 1974 Jun; 124(22):340-4. PubMed ID: 4275492
[No Abstract] [Full Text] [Related]
6. Failures of L-dopa.
Paulson GW
Ohio State Med J; 1973 Dec; 69(12):896-8. PubMed ID: 4769406
[No Abstract] [Full Text] [Related]
7. [10 years of L-DOPA therapy of Parkinson's syndrome].
Birkmayer W
Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
[No Abstract] [Full Text] [Related]
8. [Treatment of Parkinson's disease with L-dopa].
Guglielmi L; Vecchi L
Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
[No Abstract] [Full Text] [Related]
9. [Side effects occurring in the course of treatment of parkinsonism with L-dopa].
Kuran W
Neurol Neurochir Pol; 1973; 7(4):587-94. PubMed ID: 4583001
[No Abstract] [Full Text] [Related]
10. Amantadine hydrochloride in treatment of Parkinsonism.
Nagaswami S; Nagaswami R
Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
[No Abstract] [Full Text] [Related]
11. L-dopa for parkinsonism.
Reveno WS; Bauer RB; Rosenbaum H
Geriatrics; 1973 Jan; 28(1):86-8. PubMed ID: 4683093
[No Abstract] [Full Text] [Related]
12. [Long term treatment of a parkinsonism with l-dopa].
Presthus J
Tidsskr Nor Laegeforen; 1973 Oct; 93(28):2111-3. PubMed ID: 4590069
[No Abstract] [Full Text] [Related]
13. [Current treatment of Parkinson syndrome with L-dopa].
Gerstendbrand F; Gründig E; Musiol A
Pol Tyg Lek; 1972 May; 27(21):798-800. PubMed ID: 4555002
[No Abstract] [Full Text] [Related]
14. L-dopa therapy in Parkinson's disease.
Lipman IJ
Va Med Mon (1918); 1971 May; 98(5):242-8. PubMed ID: 4931138
[No Abstract] [Full Text] [Related]
15. [Long-term treatment of Parkinsonism with L-dopa].
Presthus J; Holmsen R
Tidsskr Nor Laegeforen; 1972 Nov; 92(33):2262-6. PubMed ID: 4630916
[No Abstract] [Full Text] [Related]
16. Modification of Parkinsonism--chronic treatment with L-dopa.
Cotzias GC; Papavasiliou PS; Gellene R
N Engl J Med; 1969 Feb; 280(7):337-45. PubMed ID: 4178641
[No Abstract] [Full Text] [Related]
17. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
Wälzholz U
Dtsch Med Wochenschr; 1972 Apr; 97(17):686 passim. PubMed ID: 4554502
[No Abstract] [Full Text] [Related]
18. L-dopa in the treatment of Parkinsonism; a preliminary appraisal.
Stellar S; Mandell S; Waltz JM; Cooper IS
J Neurosurg; 1970 Mar; 32(3):275-80. PubMed ID: 5416909
[No Abstract] [Full Text] [Related]
19. [L-tryptophan therapy of DOPA psychoses].
Birkmayer W; Neumayer E
Nervenarzt; 1972 Feb; 43(2):76-8. PubMed ID: 4501978
[No Abstract] [Full Text] [Related]
20. Interactions of L-dopa and amantadine in patients with Parkinsonism.
Cox B; Danta G; Schnieden H; Yuill GM
J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):354-61. PubMed ID: 4714097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
